Clinical Trial

A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution

Study acronym: Distribution
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2025 (before its estimated March 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical study is to evaluate the biodistribution of \[89Zr\]-Oxine-NCR100 injection in subjects with knee osteoarthritis after local injection and the kinetic behavior characteristics of zirconium-labeled cells at the injection site and various organs or tissues. It is a single-dose, open-label study in adult KOA subjects.
Trial Details
NCT Number NCT07139431
Lead Sponsor Nuwacell Biotechnologies Co., Ltd.
Conditions KOA
Enrollment 6 participants
Start Date 2025-08-29
Primary Completion 2026-03-06 (estimated)
Study Completion 2028-04-21 (estimated)
Updated on ClinicalTrials.gov 2025-08-24